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Abstract In developed countries, acute gastroenteritis
(AGE) is a major source of morbidity. However, only a
few studies have estimated its incidence and the
associated medical burden. This population-based study
determined the incidence of community-acquired AGE
patients seeking medical care and the relative role of
various pathogens. Stool samples from patients with
AGE presenting to a general practitioner (GP), pediatri-
cian, or specialist in internal medicine for that reason
were screened for various bacterial and viral enteropath-
ogens. A control group was established as well.
Incidences were calculated by the number of positive
patients divided by the general population. The study
was performed in north-west Germany in 2004. The
incidence of AGE patients requiring medical consultation
was 4,020/100,000 inhabitants. Children (<5 years of
age) were at the highest risk (13,810/100,000 inhabi-
tants). Of the patients, 6.6% were tested positive for an
enteropathogenic bacteria and 17.7% for a viral agent.
The predominant pathogens were norovirus (626/100,000)
and rotavirus (270/100,000). Salmonella was the most
frequently detected bacteria (162/100,000). The results
presented confirm AGE and, specifically, AGE of viral
origin as a major public health burden in developed
countries.
Introduction
Acute gastroenteritis (AGE) characterized by vomiting,
diarrhea, and dehydration is prevalent worldwide and is
associated with high rates of mortality in developing
countries [1, 2]. In more developed regions, AGE is a
frequent cause of hospitalization, especially in young
children [3].
Epidemiological studies from several European
countries provide data on the incidence of AGE, risk
factors, and the associated health burden [4–12]. German
studies focused on young children [13, 14] ,w h i l ed a t ao n
primary care consultations across all ages is lacking..
Findings are likely to differ between European countries
due to nutritional habits, health behavior of the popula-
tion, and differently set up health services [4, 7, 8]. The
incidence of AGE cases presenting to general practice was
reported to be 800/100,000 inhabitants per year in The
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To reduce the incidence of AGE on a national and
European level, changes were made to cattle and poultry
breeding practices and the population was informed about
hygienic measures over the last two decades. These
measures significantly reduced the incidence of salmonel-
losis [15, 16] and most likely contributed to a shift in the
relative contribution of pathogens that are currently causing
AGE. Therefore, data demonstrating the relative importance
of different viral, bacterial, and parasitic agents in causing
AGE does need continuous updates since the distribution
and relative importance of pathogens are likely to change
over time. Moreover, the relevance of risk factors may be
subject to change as well.
Nowadays, viral AGE is more frequently acknowledged,
due partly to improved diagnostic methods and new virus
variants, e.g., norovirus subtypes showing epidemic spread,
as well as an increase in the number of outbreaks [17–19].
It has been acknowledged that persons may continue to
excrete an enteropathogen after an episode of AGE or may
even be an asymptomatic shedder without previous disease
[20, 21]. Asymptomatic carriers of viral or bacterial
pathogens may have epidemiological importance due to
their potency as a source of infection.
Various bacterial and viral enteropathogens are enclosed
in the German surveillance system. However, studies from
England and Ireland showed a systematic underreporting of
AGE in national surveillance systems [4, 10]. Incidences
derived from surveillance systems are likely to be smaller
than the incidences found in population-based studies.
The aims of the present study were to determine the
incidence of community-acquired AGE cases presenting to
general practice and to investigate the relative role of
various bacterial and viral pathogens. Secondary aims were
to identify risk factors for microorganism-specific AGE and
determine the occurrence of asymptomatic carriers of viral
or bacterial pathogens and multiple infections .
Methods
Study population
Between 1 January and 31 December 2004, all general
practitioners (GPs) and specialists in pediatrics and internal
medicine in an urban (suburbs of Bremen; 40,268 inhab-
itants) and rural area (Wesermarsch; 20,402 inhabitants) of
Germany were asked to send stool samples from all patients
presenting with AGE for laboratory investigation. In
Germany, patients have free choice as to whether they
consult a GP, pediatrician, or specialist in internal medicine.
Forty-seven out of 67 physicians (70%) registered in the
study area participated actively and continuously in the
study. The geographical and social conditions of these areas
were considered to be particularly suitable for an epidemi-
ological study: the urban area is separated from the rest of
the city by the Weser River, while the rural area is limited
by the North Sea and the broadening Weser River on three
sides. It was expected that only very few patients would
consult a physician outside of these study areas due to the
special geographical conditions and accessibility of health
care services.
Diarrhea was defined as the excretion of at least two
loose and malodorous stools in breastfed infants and at least
two loose stools in a 24-h period for all other patients [22].
Patients diagnosed with inflammatory bowel disease, celiac
disease, cystic fibrosis, food intolerance, and malignancy
were excluded from participation, in addition to patients on
antibiotics or chemotherapy at the time of presentation.
To establish a control group, physicians were asked to
send stool specimens from patients living in the same study
areas who presented with symptoms other than diarrhea and
vomiting. Patients and controls were asked to complete a
questionnaire about their recent exposure to other people
with diarrhea or about the consumption of food including
poultry, unpasteurized milk, or other. In addition, we asked
for symptoms and the course of their illness.
Case data was de-duplicated to ensure that one indivi-
dual case was not included twice after presentation to
different doctors.
All patients and controls or their parents or guardians
gave written informed consent for participation in this
study. The study protocol and data handling were approved
by the local ethics committee.
Microbiological methods
Stool specimens were analyzed for Campylobacter spp.,
Salmonella enterica serovars, Yersinia spp., Shigella spp.,
enterotoxin-producing Staphylococcus aureus (detection of
the marker genes sea, seb, sec, sed, see, seg, seh, sei, sej
[23, 24]), Clostridium difficile, Aeromonas spp., and
Plesiomonas spp. All specimens were analyzed as follows:
1 g of stool was plated on a combination of Columbia
blood agar, Endo agar, and selective agars (CIN agar for
Yersinia spp., Önöz and Leifson agar for Salmonella and
Shigella spp., Sorbitol-MacConkey [SMAC] and CT-
SMAC agar for Shiga toxin-producing E. coli,a n d
Charcoal Cefoperazon Deoxycholate agar [CCDA] and
selenite broth for the detection of Campylobacter spp.).
The CCDA and selenite broth were incubated in micro-
aerophilic conditions and bacterial growth was detected as
described previously [25].
The detection of marker genes for enteropathogenic E.
coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxic E.
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and enterohaemorrhagic E. coli (EHEC) was performed as
described previously [28].
Virus detection
Enzyme immunoassay (EIA) was used for the detection
of rotavirus, astrovirus, and adenovirus. A total of 100 μlo f
stool specimen was diluted in appropriate amounts of
sample buffer included in the commercial kit (DakoCyto-
mation Ltd., Cambridgeshire, UK). The IDEIA™ kit
detects group A rotaviruses, while the adenovirus EIA
detects all human adenovirus serotypes. The astrovirus EIA
works with a genus-specific combination of monoclonal
and polyclonal antibodies and a special amplification
system.
Nested polymerase chain reaction (PCR) was used for
the detection of noroviruses. A total of 50 μl of stool
specimen was diluted in 200 μl of phosphate buffered
saline (PBS). Viral RNA was extracted by the Purescript
Total RNA Isolation (Gentra Systems, Minneapolis, MN,
USA) and GI and GII norovirus was detected by nested RT-
PCR, as previously reported [29].
Statistics
Laboratory findings and responses from questionnaires
were entered into a Microsoft Access™ database. The data
were analyzed in Microsoft Excel™, where incidences,
95% confidence intervals (CI95), and odds ratios (OR) were
calculated. Pathogen-specific incidences were calculated by
the number of positive patients divided by the general
population. For the calculation of incidences, data were
t a k e nf r o mp o p u l a t i o nc e n s u si nB r e m e na n dL o w e r
Saxony (http://www.nls.niedersachsen.de and Statistisches
Landesamt Bremen, data on file). The total population of
the catchment areas was diminished by that part of the
population served by the non-participating physicians.
Incidences were adjusted for age using direct standardiza-
tion based on the German age distribution data for 2003
(http://www.destatis.de); for patients who lived in the study
area but consulted a physician elsewhere; and for patients
who refused to participate in this study. These data were
obtained from the local public health authorities (LPHA)
(Gesundheitsamt Bremen and Gesundheitsamt Weser-
marsch, Brake, data on file). For the calculation of
rotavirus, adenovirus, and astrovirus incidences, it was
assumed that insufficient stool quantity with subsequent
non-examination of these viruses was independent of the
presence of these viruses. Hence, the expected number of
infections among the non-examined stool samples was
derived from the percentage of positive stool samples found
in the group of examined patients.
Logistic regression analysis was performed using SAS
System, Release 9.1 (SAS Institute Inc., Cary, NC, USA) to
determine the variables that were independently associated
with the risk of AGE. Variables were selected in a stepwise
backward manner (maximum likelihood), in which the least
significant variable was excluded at each step. The agent-
specific morbidity was calculated as the percentage of
symptomatic patients out of the total number of study
participants positive for that agent.
Qualitative variables were compared by the χ
2 test or
Fisher’s exact test, as appropriate. Significance was defined
as P<0.05 and high significance as P<0.001. The LPHA
also supplied data on the occurrence of clusters (i.e., two or
more cases of AGE caused by the same microbiological
agents), which were identified by telephone investigation—
laboratory tests were not requested. These additional cases
identified by the LPHAwere not included in the calculation
of incidences and the analysis of risk factors.
Results
In total, 1,630 patients and controls were included in the
analyses. Of these, 1,463 (90%) returned a completed
questionnaire. A total of 1,086 specimens were collected
from patients with diarrhea, 639 in the urban area and 447
in the rural area. From the controls, 544 specimens were
collected, 338 specimens in the urban area and 206
specimens in the rural area. The sex and age distribution
of the study population is shown in Table 1.
Due to insufficient stool quantities, some samples could
not be tested for all viruses and bacteria. Out of 1,630 stool
specimens, 1,580 (96.9%) were tested for enteropathogenic
bacteria, 1,585 (97.2%) were tested for norovirus, and
1,338 (82.1%) were tested for all four viral agents (Table 2).
Incidence of gastroenteritis
The overall incidence of AGE requiring medical consulta-
tion was 4,020/100,000 inhabitants (CI95 [1,879; 6,687]),
with no significant difference between the urban and rural
areas.
Children younger than five years of age had the
highest incidence of AGE requiring medical consultation
(13,810/100,000; CI95 [6,819; 21,601]), which was sig-
nificantly different from the rest of the population (P<
0.001, OR=3.88; CI95 [3.3; 4.6]). In this age group, one
out of six children consulted a physician due to AGE in
the urban area (15,967/100,000; CI95 [7,979; 24,691]), in
contrast to one out of ten children in the rural area
(10,791/100,000; CI95 [5,230; 17,368]). This difference
was significant (P=0.008, OR=1.57; CI95 [1.1; 2.2]).
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highly significant difference in incidences between the
rural and urban areas (P<0.001, OR=2.41; CI95 [1.8; 3.2])
(Table 3).
In the urban area, the highest incidences of medical
consultations due to AGE were from October through to
December, whereas in the rural area, the highest incidences
were found in January, March, and April, which is
coincident with the different pathogen patterns between
the two areas
Incidence of specific viral and bacterial pathogens
A total of 80 out of 1,580 specimens tested positive for
enteropathogenic bacteria (72 patients, 6.6%, and eight
controls, 1.5%), while 320 out of 1,585 specimens tested
positive for a viral agent (280 patients, 17.7%, and 40
controls, 2.5%). Overall, viral and bacterial pathogens were
identified in 35% of specimens from patients with AGE
(Table 2). Months with high incidences of viral pathogens
revealed a higher portion of positive stool specimens than
months that showed lower incidences of viral pathogens
(Fig. 1).
Norovirus and rotavirus were the most frequently
detected pathogens. Norovirus was found in 16% of all
cases with AGE (Table 2). The incidence was 626/100,000
inhabitants (CI95 [287; 1,071]). Norovirus was detected
all-year-round, with two peaks. The months with the
highest incidences of norovirus infection were March and
December in the rural area and November and December
in the urban area. Morbidity for norovirus-related AGE
was 89.2%.
Rotavirus was responsible for 270 episodes/100,000
inhabitants (CI95 [124; 467]). The incidence of rotavirus-
related AGE in children younger than five years of age
(2,574/100,000, CI95 [1,193; 4,455]) was higher than that
for noroviruses in this age group (2,302/100,000, CI95
[1,065; 4,006]), thus, confirming that rotavirus is the most
important pathogen causing AGE in young children.
Rotavirus-related AGE occurred all-year-round, with a
distinctive seasonal peak in March and April. Morbidity
for rotavirus-related AGE was 84.1%.
Urban area Rural area
Patients with diarrhea Controls Patients with diarrhea Controls
Total 639 (100%) 338 (100%) 447 (100%) 206 (100%)
Male 308 (48.2%) 154 (45.6%) 242 (54.1%) 88 (42.7%)
Female 331 (51.8%) 184 (54.4%) 205 (45.9%) 118 (57.3%)
Age <5 years 76 (11.9%) 17 (5.0%) 50 (11.2%) 8 (3.9%)
5–14 years 80 (12.5%) 58 (17.2%) 98 (21.9%) 39 (18.9%)
15–59 years 362 (56.7%) 196 (58.0%) 238 (53.2%) 83 (40.3%)
>59 years 121 (18.9%) 67 (19.8%) 61 (13.6%) 76 (36.9%)
Table 1 Demographic structure
of patients and controls, shown
as number of probands (percent)
Table 2 Detected microorganisms
Patients (n=1,086) Controls (n=544)
Number tested % positive Incidence/100,000 inhabitants, [confidence interval] Number tested % positive
Norovirus 1,053 16 626 [287; 1,071] 532 3.4
Rotavirus 875 7 270 [124; 467] 464 2.8
Astrovirus 875 3 111 [51; 196] 464 1.7
Adenovirus 875 2.9 113 [52; 199] 464 0.2
Salmonella 1,046 2 162 [74; 290] 534 0
Campylobacter spp. 1,046 1.2 55 [25; 101] 534 0
Yersinia enterocolitica 1,046 0.9 34 [16; 65] 534 0
Plesiomonas 1,046 0.1 Not calculated 534 0
Aeromonas spp. 1,046 0.7 31 [14; 58] 534 0.4
EPEC 1,046 0.3 Not calculated 534 0.6
Enterotoxin-encoding S. aureus 1,046 1.7 67 [31; 120] 534 0.6
No enteropathogen found 709 (65%) 484 (89%)
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are shown in Table 2. Children younger than five years
were at the highest risk, but astroviruses were an important
agent for viral AGE in all age groups. Adenoviruses were
rarely detected in patients aged five years or older.
Salmonella was the most frequently detected bacteria
found in patients with AGE (162/100,000, CI95 [74; 290]),
followed by enterotoxin gene-carrying S. aureus (67/100,000,
CI95 [31; 120]) and Campylobacter spp. (55/100,000, CI95
[25; 101]). The age groups with the highest incidences of all
of these bacterial agents were children aged 0–14 years.
Salmonella infections showed a typical seasonal distribution,
prevailing between May and October. Salmonella and
Campylobacter spp. showed 100% morbidity.
Aeromonas spp. and Y. enterocolitica had comparable
incidences. Plesiomonas spp. and EPEC were found in one
and three cases, respectively (Table 2). EaggEC, EHEC,
EIEC, ETEC, or Shigella spp. were not isolated.
A total of 34 positive stool specimens from patients were
carrying two or more infectious agents (Table 4). In
controls, no co-infections were detected.
Table 5 shows the typical symptoms of AGE caused by
the various viral (frequently vomiting) and bacterial
(frequently fever) enteropathogens. Table 6 shows the risk
factors for acquiring AGE.
Discussion
This is the first population-based study presenting the
incidence of community-acquired AGE requiring medical
consultation across all age groups within defined areas over
a complete year. This study shows that AGE is a very
frequent disease, with children aged 0–4 years particularly
at risk. Viral and/or bacterial pathogens were detected in
35% of specimens from patients with AGE. Viral pathogens
were detected far more often than bacterial pathogens.
We believe that these results might be representative for
most of Germany and even other European countries.
Four percent of the study population consulted a
physician due to diarrhea in 2004 (4,020/100,000). This
incidence is higher than that reported by Wheeler et al. in
England (3,300/100,000 inhabitants) [4]. Furthermore, it is
almost five times higher than the incidence reported by de
Wit et al. in The Netherlands (800/100,000) [7]. It is
possible that the guidelines of the Dutch College of General
Practitioners (NHG)—which state that patients with an
uncomplicated case of AGE can be dealt with by phone
consultation (http://nhg.artsennet.nl)—may dissuade
patients from seeking medical assistance and, thus, explain
the low incidence of AGE found in The Netherlands.
Slightly different case definitions between the studies may
be another explanation for the varying incidences.
The incidence of AGE reported in this study proves it to
be a major public health burden and suggests that AGE
may have important cost implications for the healthcare
system. Information about the magnitude of the public
health burden of AGE is urgently needed in Germany.
Tam et al. [30] described risk factors associated with
presentation to a GP in patients with infectious intestinal
diseases. They suggest how these risk factors may introduce
selection bias when performing a case–control study using
Age groups Rural area Urban area P-value, OR, CI95
<5 years 10,791 [5,230; 17,368] 15,967 [7,979; 24,691] 0.008, 1.57 [1.1; 2.2]
5–19 years 4,177 [1,953; 7,010] 5,178 [2,435; 8,611] 0.15, 1.24 [0.9; 1.6]
20–59 years 4,070 [1,902; 6,789] 2,806 [1,303; 4,718] 0.001, 0.76 [0.6; 0.9]
>60 years 2,421 [1,121; 4,131] 5,321 [2,504; 8,813] <0.001, 2.41 [1.8; 3.2]
Table 3 Incidence of AGE per
100,000 inhabitants in different
age groups in the study areas
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Fig. 1 Monthly distribution of pathogens
Table 4 Co-infections
Combination of infectious agents No.
Norovirus and rotavirus 10
Norovirus and enterotoxin-encoding S. aureus 5
Norovirus and astrovirus 4
Norovirus and Salmonella 3
Rotavirus and adenovirus 2
Astrovirus and rotavirus, norovirus and Campylobacter coli,
astrovirus and S. aureus, rotavirus and S. aureus, rotavirus and
Aeromonas spp., norovirus and Aeromonas spp., rotavirus and
Salmonella, Y. enterocolitica and Salmonella, Y. enterocolitica
and enteropathogenic Escherichia coli
1
Norovirus, astrovirus and S. aureus 1
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Age (years) Rural
area
Contact within the last ten days Consumption of …
within the last ten
days
Journey abroad
within the last two
months
<5 5–15 >59 With persons
with diarrhea
With
animals
With
cattle
Poultry Other
foods
Diarrhea 0.02 0.009 0.01 n.s. <0.001 n.s. n.s. 0.04 <0.001 0.01
1.6 0.6 0.7 1.9 1.3 5.2 1.8
Norovirus n.s. n.s. 0.03 n.s. <0.001 0.03 n.s. n.s. n.s. n.s.
1.6 2.7 0.7
Rotavirus <0.001 n.s. n.s. 0.04 0.01 n.s. n.s. n.s. n.s. n.s.
4.4 1.8 2.1
Astrovirus n.s. n.s. n.s. n.s. 0.04 n.s. n.s. n.s. 0.006* n.s.
2.3 3.2
Campylobacter spp. n.s. 0.03 n.s. 0.02 n.s. n.s. n.s. n.s. <0.001** n.s.
4.2 4.9 11.4
Salmonella <0.001 <0.001 n.s. n.s. n.s. n.s. n.s. n.s. <0.001*** n.s.
8.8 16.3 7.8
Enterotoxin gene-
encoding S.
aureus
n.s. 0.01 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s.
2.8
The following variables were tested but not determined as significantly associated with the risk of infectious gastroenteritis due to any of the tested
agents: gender, pets in the household, contact with poultry within the last ten days, contact with other domestic animals within the last ten days,
consumption of unpasteurized milk within the last ten days
n.s.: not significant
*Fish, beef, pork, milk products, vegetables, fruit
**Milk products, beef, vegetables, fruit
***Eggs, egg products, milk
Table 5 Self-reported symptoms of patients
Self-reported symptoms Norovirus
(n=168)
Rotavirus
(n=61)
Astrovirus
(n=26)
Adenovirus
(n=25)
Salmonella
(n=21)
Campylobacter
spp. (n=13)
Yersinia
enterocolitica
(n=9)
S. aureus
(n=28)
%% % %%% % %
Watery stool 75.4 65.6 47.0 42.1 68.8 63.4 37.0 55.6
Loose stool 43.7 54.6 42.7 38.3 31.7 17.1 61.7 61.7
Bloody stool 0.7 0 0 3.8 5.3 8.5 12.3 18.5
Abdominal pain 37.7 32.8 51.3 30.7 10.6 17.1 49.4 55.6
Loss of body weight 37.7 41.9 51.3 88.1 5.3 59.8 12.3 30.9
Fever 15.2 36.4 8.5 7.7 26.5 42.7 61.7 24.7
Fatigue 25.2 21.9 17.0 3.8 0 8.5 24.7 18.5
Vomiting 60.8 56.5 34.2 30.7 31.8 17.1 0 37.0
Median Median Median Median Median Median Median Median
Max. no. of bowel
evacuations per 24 h
5 5 8 6 14.5 11 6 6
Additional symptoms
a 1–10 2–5; 7–10 2; 3; 5–7 3; 10 2 none 1–31 –3; 6; 8
aAdditional symptoms: 1=arthralgia, 2=headache, 3=nausea, 4=vertigo, 5=dorsalgia, 6=heartburn, 7=meteorism, 8=fever chills, 9=limb pain,
10=lack of appetite
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with biological factors, such as disease severity, and social
factors, such as educational level [30]. Some patients may
not have seen a physician in spite of severe AGE, and some
patients may have seen a physician in the presence of mild
AGE. Wheeler et al. described that the ratio of community
incidence to GP presentation incidence differs depending on
the pathogen. Patients infected by Salmonella spp. were
more likely to present to their GP than patients infected by
rota- or norovirus [4]. Therefore, it is likely that the relative
frequency of pathogens in patients may differ from the
relative frequency of pathogens in the community.
Viral and bacterial pathogens were identified in about
one third of the specimens. The proportion of positive
samples is in agreement with the findings of Sinclair et al.
and de Wit et al. [7, 8, 31]. There are several factors which
might explain why no causative agent was detected in the
remaining specimens. Organisms may have escaped detec-
tion due to the low numbers present in specimens, the delay
between the onset of symptoms and collection of speci-
mens, transport loss due to overgrowth by physiological
stool flora, or better laboratory assays. In some cases,
patients may have been infected by enteropathogens that
were not included in the diagnostic scope—for instance, by
parasites or rare viruses. Finally, diarrhea may occur as a
symptom in non-infectious illnesses, although the majority
of which were excluded by the study design. Further
research is urgently needed to refine the methods used for
the efficient detection of known causative agents of AGE
and to discover as yet unknown pathogens.
Viral pathogens were detected more frequently than
bacterial pathogens. This finding was independent from
age, suggesting that viruses are the leading cause of AGE in
all age groups. This finding suggests that it is not
appropriate to perform diagnostic procedures on apparently
sporadic cases of AGE for bacterial pathogens only. Of
note, 34 stool specimens were tested positive for two or
more viral and/or bacterial pathogens. Based on the clinical
information available, it was not possible to determine if
one of the pathogens or a combination were responsible for
the diarrheal symptoms.
Rotavirus infections occurred significantly more often in
children aged five years or younger than in adults, while
norovirus infections occurred significantly more often in
people aged 60 years or older. These findings are most
likely explained by the fact that primary infection with
rotavirus confers protective immunity against symptomatic
rotavirus infection, with subsequent infections later in life
remaining asymptomatic or associated with milder symp-
toms [32]. Knowledge on immunity to norovirus is
incomplete [33, 34]. No vaccines against norovirus are
available yet, while two vaccines against rotavirus are
currently licensed in Europe [35–37]. Introducing a safe
and effective vaccine against rotavirus will most likely
reduce the morbidity and mortality of AGE considerably,
especially in young children.
A pathogen was detected in 48 samples from controls. In
these cases, viral pathogens were found more frequently
than bacterial pathogens. After an episode of AGE, patients
may continue to excrete the pathogen for variable periods.
Patients may even be asymptomatic shedders without
previous disease [20, 21]. de Wit et al. described asymp-
tomatic carriers of rotavirus, norovirus, adenovirus, and
astrovirus in healthy controls [7]. This can have epidemi-
ological importance due to their capacity to act as a source
of infection, which is especially relevant for viral pathogens
with high tenacity, low infective dose, and predominant
person-to-person transmission. Asymptomatic shedders
may be important vectors of these viruses into healthcare
institutions, where the burden of outbreaks has risen over
recent years [38].
In this study, close contact with persons who experi-
enced diarrhea within the previous ten days was an
important risk factor for acquiring viral AGE. This suggests
that many cases were not sporadic but were part of
outbreaks. For AGE, due to Salmonella and Campylobacter
spp. a significant risk factor was the consumption of certain
foods implicated by the patients.
Incidences of AGE caused by various viral and bacterial
pathogens found in this study were 2.5–10 times higher
than incidences based on reported cases within the German
surveillance system (http://www.rki.de). The reported inci-
dence of norovirus in 2004 was 77.1/100,000 inhabitants
compared with 626/100,000 inhabitants in this study.
Findings for rotavirus (45.5 versus 270/100,000 inhab-
itants) and Salmonella (68.7 versus 162/100,000 inhab-
itants) confirmed the systematic underreporting in the
surveillance system. Reasons for this are summarized in
the concept of the AGE disease pyramid: only a fraction of
community cases of AGE seek medical care and only a
fraction of those will be requested to or will submit a stool
sample for testing. Furthermore, only a fraction of stool
samples will be tested positive for a causative agent, as has
been reported in other countries with national surveillance
systems [4, 10, 30, 39].
In conclusion, this population-based study on the
incidence of community-acquired AGE showed a high
disease burden and a marked underreporting of the disease
and demonstrated a significant predominance of viral AGE
throughout the year. This study leads the way for inves-
tigations to assess the full extent of AGE. Additional
studies on the disease burden should follow.
Acknowledgments Dr. C. Karsten is a resident in pediatrics at the
Children’s Hospital Prof. Hess, Bremen, Germany. Her research
interests include infectious diseases and public health.
Eur J Clin Microbiol Infect Dis (2009) 28:935–943 941This study is supported by the Federal Ministry of Education and
Research (Research Fund 01KI0205).
No author has any conflict of interest.
Aspects of this study have been presented at the 25th Annual
Meeting of the European Society of Pediatric Infectious Diseases,
Porto, Portugal, May 2007.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. O’Ryan M, Prado V, Pickering LK (2005) A millennium update
on pediatric diarrheal illness in the developing world. Semin
Pediatr Infect Dis 16:125–136. doi:10.1053/j.spid.2005.12.008
2. Parashar UD, Bresee JS, Glass RI (2003) The global burden of
diarrhoeal disease in children. Bull World Health Organ 81:236
3. Lugauer S, Überall MA, Schmitt-Grohé S et al (2000) Inzidenz
und Symptomatik von hospitalisierten Gastroenteritiden in einer
Kohorte von 10.271 Säuglingen und Kleinkindern. Monatsschr
Kinderheilkd 148:119–122. doi:10.1007/s001120050021
4. Wheeler JG, Sethi D, Cowden JM et al (1999) Study of infectious
intestinal disease in England: rates in the community, presenting to
generalpractice,andreportedtonational surveillance.TheInfectious
Intestinal Disease Study Executive. BMJ 318:1046–1050
5. van den Brandhof WE, De Wit GA, de Wit MA et al (2004) Costs
of gastroenteritis in The Netherlands. Epidemiol Infect 132:211–
221. doi:10.1017/S0950268803001559
6. Roberts JA, Cumberland P, Sockett PN et al (2003) The study of
infectious intestinal disease in England: socio-economic impact.
Epidemiol Infect 130:1–11. doi:10.1017/S0950268802007690
7. de Wit MA, Koopmans MP, Kortbeek LM et al (2001)
Gastroenteritis in sentinel general practices, The Netherlands.
Emerg Infect Dis 7:82–91
8. de Wit MA, Koopmans MP, Kortbeek LM et al (2001) Sensor, a
population-based cohort study on gastroenteritis in the Nether-
lands: incidence and etiology. Am J Epidemiol 154:666–674.
doi:10.1093/aje/154.7.666
9. Tompkins DS, Hudson MJ, Smith HR et al (1999) A study of
infectious intestinal disease in England: microbiological findings
in cases and controls. Commun Dis Public Health 2:108–113
10. Scallan E, Fitzgerald M, Collins C et al (2004) Acute gastroen-
teritis in northern Ireland and the Republic of Ireland: a telephone
survey. Commun Dis Public Health 7(1):61–67
11. Kuusi M, Aavitsland P, Gondrosen B et al (2003) Incidence of
gastroenteritis in Norway—a population-based survey. Epidemiol
Infect 131(1):591–597. doi:10.1017/S0950268803008744
12. Gauci C, Gilles H, O’Brien S et al (2007) The magnitude and
distribution of infectious intestinal disease in Malta: a population-
based study. Epidemiol Infect 135(8):1282–1289
13. Ehlken B, Laubereau B, Karmaus W et al (2002) Prospective
population-based study on rotavirus disease in Germany. Acta
Paediatr 91:769–775. doi:10.1080/08035250213227
14. van Damme P, Giaquinto C, Huet F et al (2007) Multicenter
prospective study of the burden of rotavirus acute gastroenteritis
in Europe, 2004–2005: the REVEAL study. J Infect Dis 195
(Suppl 1):4–16. doi:10.1086/516714
15. Ethelberg S, Olsen KE, Gerner-Smidt P et al (2004) Household
outbreaks among culture-confirmed cases of bacterial gastrointes-
tinal disease. Am J Epidemiol 159:406–412. doi:10.1093/aje/
kwh049
16. van Pelt W, de Wit MA, Wannet WJ et al (2003) Laboratory
surveillance of bacterial gastroenteric pathogens in The Nether-
lands, 1991–2001. Epidemiol Infect 130:431–441
17. Lopman BA, Reacher M, Gallimore C et al (2003) A summertime
peak of “winter vomiting disease”: surveillance of noroviruses in
England and Wales, 1995 to 2002. BMC Public Health 3:13.
doi:10.1186/1471-2458-3-13
18. Lopman B, Vennema H, Kohli E et al (2004) Increase in viral
gastroenteritis outbreaks in Europe and epidemic spread of new
norovirus variant. Lancet 363:682–688. doi:10.1016/S0140-6736
(04)15641-9
19. van Duynhoven YT, de Jager CM, Kortbeek LM et al (2005) A
one-year intensified study of outbreaks of gastroenteritis in The
Netherlands. Epidemiol Infect 133:9–21. doi:10.1017/
S0950268804002936
20. Moore JE, Corcoran D, Dooley JS et al (2005) Campylobacter.
Vet Res 36:351–382. doi:10.1051/vetres:2005012
21. Amieva MR (2005) Important bacterial gastrointestinal pathogens
in children: a pathogenesis perspective. Pediatr Clin North Am
52:749–777. doi:10.1016/j.pcl.2005.03.002
22. Huppertz H-I, Busch D, Schmidt H et al (1996) Diarrhea in young
children associated with Escherichia coli non-O157 organisms
that produce Shiga-like toxin. J Pediatr 128:341–346.
doi:10.1016/S0022-3476(96)70278-0
23. Becker K, Friedrich AW, Lubritz G et al (2003) Prevalence of
genes encoding pyrogenic toxin superantigens and exfoliative
toxins among strains of Staphylococcus aureus isolated from
blood and nasal specimens. J Clin Microbiol 41:1434–1439.
doi:10.1128/JCM.41.4.1434-1439.2003
24. Becker K, Roth R, Peters G (1998) Rapid and specific detection of
toxigenic Staphylococcus aureus: use of two multiplex PCR
enzyme immunoassays for amplification and hybridization of
staphylococcal enterotoxin genes, exfoliative toxin genes, and
toxic shock syndrome toxin 1 gene. J Clin Microbiol 36(9):2548–
2553
25. Endtz HP, Ruijs GJ, Zwinderman AH et al (1991) Comparison of
six media, including a semisolid agar, for the isolation of various
Campylobacter species from stool specimens. J Clin Microbiol
29:1007–1010
26. Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin
Microbiol Rev 11:142–201
27. Huppertz HI, Rutkowski S, Aleksic S et al (1997) Acute and
chronic diarrhoea and abdominal colic associated with enter-
oaggregative Escherichia coli in young children living in western
Europe. Lancet 349:1660–1662. doi:10.1016/S0140-6736(96)
12485-5
28. Friedrich AW, Bielaszewska M, Zhang WL et al (2002)
Escherichia coli harboring Shiga toxin 2 gene variants: frequency
and association with clinical symptoms. J Infect Dis 185:74–84.
doi:10.1086/338115
29. Oh DY, Gaedicke G, Schreier E (2003) Viral agents of acute
gastroenteritis in German children: prevalence and molecular
diversity. J Med Virol 71:82–93. doi:10.1002/jmv.10449
30. Tam CC, Rodrigues LC, O’Brien SJ (2003) The study of
infectious intestinal disease in England: what risk factors for
presentation to general practice tell us about potential for selection
bias in case-control studies of reported cases of diarrhoea. Int J
Epidemiol 32:99–105. doi:10.1093/ije/dyg007
31. Sinclair MI, Hellard ME, Wolfe R et al (2005) Pathogens causing
community gastroenteritis in Australia. J Gastroenterol Hepatol
20:1685–1690. doi:10.1111/j.1440-1746.2005.04047.x
32. Anderson EJ, Weber SG (2004) Rotavirus infection in adults.
Lancet Infect Dis 4:91–99. doi:10.1016/S1473-3099(04)00928-4
33. Wyatt RG, Dolin R, Blacklow NR et al (1974) Comparison of
three agents of acute infectious nonbacterial gastroenteritis by
cross-challenge in volunteers. J Infect Dis 129:709–714
942 Eur J Clin Microbiol Infect Dis (2009) 28:935–94334. Parrino TA, Schreiber DS, Trier JS et al (1977) Clinical immunity
in acute gastroenteritis caused by Norwalk agent. N Engl J Med
297:86–89
35. De Vos B, VesikariT, Linhares ACetal (2004)Arotavirus vaccinefor
prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect
Dis J 23:S179–S182. doi:10.1097/01.inf.0000142370.16514.4a
36. Dennehy PH (2005) Rotavirus vaccines: an update. Curr
Opin Pediatr 17:88–92. doi:10.1097/01.mop.0000147907.
30720.04
37. de Quadros CA, Santos JI (2004) Rotavirus: the search for the
next generation vaccine. Pediatr Infect Dis J 23:S147–S148.
doi:10.1097/01.inf.0000142520.93839.97
38. Lopman BA, Reacher MH, Vipond IB et al (2004) Epidemiology
and cost of nosocomial gastroenteritis, Avon, England, 2002–
2003. Emerg Infect Dis 10:1827–1834
39. Gauci C, Gilles H, O’Brien S et al (2007) General practitioners
role in the notification of communicable diseases—study in Malta.
Euro Surveill 12(11):E5–E6
Eur J Clin Microbiol Infect Dis (2009) 28:935–943 943